[1] |
ZHANG Huiting, LI Youlin, LI Lei, YAN Yue, YAO Ting, LI Chunlei, SHI Qi.
Toxicity of Single-Dose and Repeated-Dose Administration of Guisha Zichuan Granules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 547-553.
|
[2] |
WANG Ping, CAO Huijuan, LI Mengqi, ZHANG Guozhi, LIU Jianping, JIN Xuejing.
Toxicity of “Aconitum Carmichaelii-Pinellia Ternata” Incompatible Combination: a Systematic Review and Meta-Analysis of Experimental Studies on Rats
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 177-182.
|
[3] |
XU Meibao, PEI Yusheng, CHEN Chen, LI Wenlong, LIU Tao, CAI Tong.
Bacterial endotoxin test of (R)-lansoprazole raw material
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 852-856.
|
[4] |
LI Hongchang, GE Yunxuan, WANG Ningning, ZHOU Wei, WANG Yuguang, MA Zengchun, GAO Yue.
Research progress in roles of ginseng combined with Radix Aconiti Carmichaeli in reducing toxicity and increasing efficiency in myocardial cells
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 601-605.
|
[5] |
GE Yunxuan, WANG Yuguang, ZHANG Zhuo, MA Zengchun, GAO Yue.
Effect of hypaconitine of radix aconiti carmichaeli on hERG channels in cardiac myocytes via miR-134 regulation
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 606-610.
|
[6] |
GAO Haiyun, LI Yao, CHEN Yuxin, LI Hui, LIU Tianrui, YUAN Yuan.
Research progress in pharmacology and safe use of Boletus edulis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 507-512.
|
[7] |
HU Xiaozhen, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, ZHENG Changhui, YE Zuguang, CAO Junling.
Literature research on ancient and modern literature of Dichroae Radix and Shu lacquer
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 587-593.
|
[8] |
LEI Jingqi, ZHANG Zezhao, REN Dong, WANG Xinguo, NIU Liying.
Determination of 15 Chemical Constituents in Dandelion Leaves from Different Areas of Production Based on UPLC-MS/MS
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1256-1263.
|
[9] |
CHEN Chenxin, ZHANG Pengpeng, LIU Yongmei, YE Xiaofei, HE Jia.
Combination of zero-inflated model and Dirichlet process in detection of adverse reaction signals during post-marketing surveillance
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 651-654.
|
[10] |
TIAN Chunhua, WU Guizhi.
Implementation of periodic benefit risk evaluation reports in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1382-1384.
|
[11] |
LIU Caiping, CHAO Bao, FENG Yuanzhou, SUN Lan, LUO Yuan, YANG Jingfeng, DONG Wu, WANG Yongan, LI Yueting, ZHAO Baoquan.
Establishment of transgenic zebrafish model regulated by nr1h4 and related studies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 873-880.
|
[12] |
ZHANG Qiang, DU Pengcheng, MAN Chunrui, SUN Qian.
Network pharmacology of protection against angina pectoris by Ginkgo Biloba
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 158-163.
|
[13] |
YANG Xiaolu, CAO Shan, XIONG Bo, QIN Zhen, XIA Yun, QU Hong.
One case of serious liver injury induced by Xiaojin tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 213-216.
|
[14] |
SUN Qian, CHEN Hong, GUO Xinxin, LIU Shengwei, LIAO Yuan, JIA Lingling.
Network Pharmacology of Luteolin Protecting against Cerebral Ischemia
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 760-762.
|
[15] |
TIAN Chunhua, LIU Wei, LIU Cuili, HOU Yongfang, WANG Dan.
Progress in Implementation of ICH M1 in Post-marketing Monitoring of Drugs in China
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 763-765.
|